Tevogen Inc. Common Stock
TVGN
5 hedge funds and large institutions have $50.8M invested in Tevogen Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more ownership
Funds ownership: 0.61% → 0.61% (+0%)
2% less capital invested
Capital invested by funds: $51.6M → $50.8M (-$782K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
+$10.7K |
| 2 |
CS
Clear Street
New York
|
+$4.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.76K |
| 2 |
Morgan Stanley
New York
|
-$11 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FCM
1
FourWorld Capital Management
New York
| $24.8M | – | – | – |
|
|
CCP
2
Corbin Capital Partners
New York
| $24.5M | – | – | – |
|
|
CF
3
Cantor Fitzgerald
New York
| $1.5M | – | – | – |
|
|
RCM
4
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| $10.7K | +$10.7K | +20 | New |
|
|
CS
5
Clear Street
New York
| $4.21K | +$4.28K | +8 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$7.76K | -14 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$11 | – | – |
|
TVGN Hedge Fund Activity: Q2 2023 in Review
5 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q2 2023, worth a combined $50.8M — down 1.5% from $51.6M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TVGN positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Robinson Capital Management, opening a new position worth an estimated $10.7K. The largest seller was UBS Group, exiting entirely with an estimated $7.76K sold.
- 5 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q2 2023, up from 4 in Q1 2023.
- Funds reported $50.8M of Tevogen Inc. Common Stock stock for Q2 2023, down 1.5% quarter-over-quarter.
- 2 funds opened new Tevogen Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of +1 holder.
- The largest Tevogen Inc. Common Stock buyer in Q2 2023 was Robinson Capital Management, an estimated $10.7K added.
- The largest Tevogen Inc. Common Stock seller in Q2 2023 was UBS Group, an estimated $7.76K sold.
Based on aggregated 13F filings for Q2 2023.